• Progress in Medical Physics
• /
• v.25 no.1
• /
• pp.23-30
• /
• 2014

The purpose of this study is to evaluate the developed dose verification program for in vivo dosimetry based on transit dose in radiotherapy. Five intensity modulated radiotherapy (IMRT) plans of lung cancer patients were used in the irradiation of a homogeneous solid water phantom and anthropomorphic phantom. Transit dose distribution was measured using electronic portal imaging device (EPID) and used for the calculation of in vivo dose in patient. The average passing rate compared with treatment planning system based on a gamma index with a 3% dose and a 3 mm distance-to-dose agreement tolerance limit was 95% for the in vivo dose with the homogeneous phantom, but was reduced to 81.8% for the in vivo dose with the anthropomorphic phantom. This feasibility study suggested that transit dose-based in vivo dosimetry can provide information about the actual dose delivery to patients in the treatment room.

• Journal of radiological science and technology
• /
• v.39 no.3
• /
• pp.305-312
• /
• 2016

This study were compared with the direct measurement and indirect dose methods through various dose calculation in head and wrist. And, the modified equation was proposed considering equipment type, setting conditions, tube voltage, inherent filter, added filter and its accompanied back scatter factor. As a result, it decreased the error of the direct measurement than the existing dose calculation. Accordingly, diagnostic radiography patient dose comparison would become easier and radiogrphic exposure control and evaluation will become more efficient. The study findings are expected to be useful in patients' effective dose rate evaluation and dose reduction.

• 대한방사선방어학회:학술대회논문집
• /
• 2009.04a
• /
• pp.162-163
• /
• 2009

• Journal of Radiation Protection and Research
• /
• v.37 no.2
• /
• pp.103-107
• /
• 2012

This paper analyzes changes in the external radiation dose rate of PET-CT test patients as a part of providing basic materials for reduction of radiation exposure to PET-CT test patients. In theory the measurement of external radiation dose rate of PET-CT test patients shows that the further the distance from the patient injected with radioactive pharmaceutical and a longer time elapsement from the injection leads to a smaller amount of radiation. Particularly, the amount of radiation marked the highest in the chest was at 4.17 minutes immediately after the intravenous injection and in the head after 77.47 minutes after urination in advance to the PET-CT test. As in the generalized information, it is desired to keep distance between the patient and caretakers or professionals to reduce the amount of radiation exposure from PET-CT test patients and to resume contact the patient after the time when the radiation has reduced. If contact is unavoidable, it is desired to keep at least 200cm from the patient. In addition, the amount of radiation reached the highest in the chest at first and then in the head from 77 minutes after injection. Accordingly, it would be helpful in achieving the optimization if contact is made based on the patient's physical characteristics. This study is significant as it measures changes in radiation the dose rate by; distance from the PET-CT test patient, time elapsed, and specific parts of body. Further studies based on the findings in this paper are required to analyze changes in radiation dose rate in accordance with individual characteristics unique to PET-CT patients and to utilize the results to reduce the amount of radiation patient, caretakers and professions are exposed.

• Proceedings of the Korea Contents Association Conference
• /
• 2014.11a
• /
• pp.227-228
• /
• 2014

방사선치료의 발전으로 3차원치료보다 진보된 호흡연동방사선치료가 시행되어지고 있다. 호흡의 규칙성과 환자의 위치 재현성이 중요한 치료적응 인자이며, 호흡연동 방사선치료의 효율을 높일 수 있는 지표이다. 국가암통계상 고령의 암환자가 증가하며, 수술, 화학요법을 병행하는 암 치료법이 널리 이용이 되고 있다. 고식적인 치료를 요하는 고령의 복부 암 환자분들에 호흡연동 방사선치료법을 사용하는데 에는 호흡의 불규칙성과 체위의 재현성의 문제점으로 인한 치료 효율의 저하를 가져온다. 본 연구에서는 호흡에 의한 종양 움직임이 있는 방사선 치료에서 내부표적체적 기반의 치료계획과 호흡연동 기법을 적용한 치료계획과의 선량비교 분석하였다. 2가지 치료법 모두 정상조직 보호선량에 부합한 것으로 나타났으며 치료체적은 처방선량의 95%이상 포함된 선량분포로 적합하였다. ITV 설정을 통한 3D Plan은 고식적 치료을 목적으로 하는 고령의 환자, 체위 및 호흡의 불안정성 환자에게 처방선량의 95% 이상의 4D Plan의 치료법 보다 짧은 시간에 치료함으로써 치료효율을 높일 수 있을 거라 사료된다. 다만 정상조직보호선량(NTCP)에 부합하는지에 대한 평가가 전제되어야 한다.

• Journal of Radiation Protection and Research
• /
• v.36 no.2
• /
• pp.86-92
• /
• 2011

This study used the optically stimulated luminescence dosimeters (OSLDs), recently, received the revaluation of usefulness in vivo dosimetry, and the diode detecters to measure the skin dose of patient with the rectal cancer. The measurements of dose delivered were compared with the planned dose from the treatment planning system (TPS). We evaluated the clinical application of OSDs in radiotherapy. We measured the calibration factor of OSLDs and used the percent depth dose to verified, also, we created the three point of surface by ten patients of rectal cancer to measured. The calibration factors of OSLD was 1.17 for 6 MV X-ray and 1.28 for 10 MV X-ray, demonstrating the energy dependency of X-ray beams. Comparison of surface dose measurement using the OSLDs and diode detectors with the planned dose from the TPS, The skin dose of patient was increased 1.16 ~ 2.83% for diode detectors, 1.36 ~ 2.17% for OSLDs. Especially, the difference between planned dose and the delivery dose was increased in the perineum, a skin of intense flexure region, and the OSLDs as a result of close spacing of measuring a variate showed a steady dose verification than the diode detecters. Therefore, on behalf of the ionization chamber and diode detecters, OSLDs could be applied clinically in the verification of radiation dose error and in vivo dosimety. The research on the dose verification of the rectal cancer in the around perineal, a surface of intense flexure region, suggest continue to be.

• Journal of radiological science and technology
• /
• v.29 no.4
• /
• pp.257-260
• /
• 2006

In order to evaluate the exposure to the radiologic technologists from patients who had been administrated with radiopharmaceuticals, we measured the spatial dose rates at $5{\sim}300\;cm$ from skin surface of patients using an proportional digital surveymeter, 1.5(PET scan) and 4hr(bone scan) after injection. In results, the exposure to the technologists in each procedure was small, compared with the dose limits of the medical workers. However, the dose-response relationships in cancer and hereditary effects, referred to as the stochastic effects, have been assumed linear and no threshold models ; therefore, the exposure should be minimized. For this purpose, the measurements of spatial dose rate distributions were thought to be useful.

• Journal of the Korean Society of Radiology
• /
• v.8 no.2
• /
• pp.81-88
• /
• 2014

In diagnostic radiology, each part is examined through serial radiography in most cases of general radiography. However, the reality is that, as for diagnostic reference level, measured values have been set up only for AP projection of each part and lateral projection. In the clinical setting, cumulative dose is incurred by serial radiography of patients, and this can make comparison of diagnostic reference level and cumulative exposure dose impossible or can lead to underestimation of diagnostic reference level. In this study, measurement of cumulative dose of serial radiography of each part revealed that when converting entrance surface dose to effective dose in case it is included in the exposure field, cumulative dose measured from a maximum of 38.06% to a minimum of 0.23% of individual dose limitation of the public. Also, when converting entrance surface dose of each part that is not included in the exposure field into effective dose, it measured from a maximum of 5% to a minimum of 0.04% of individual dose limitation of the public. Results of this study show entrance surface dose substantially increases in serial radiography of each part. Therefore, it is deemed that hospitals need to establish diagnostic reference level specifically, and subdivision of radiography orders for patients is also required in order to reduce unnecessary inspections. Moreover, the need of accurate exposure field is emphasized in case of inspection of several parts.

• Journal of radiological science and technology
• /
• v.34 no.3
• /
• pp.209-214
• /
• 2011

Goal of this study was to measure effective radiation dose of highly exposed patients who were treated by TACE, interventional radiology from June to September 2010. The effective radiation dose was approximately measured by weighted DAP (dose area product) with the ionization chamber which is inserted in angiography equiment (Philips Allura Xper FD 20). Radiation dose was measured by TLD which was attached to patients' thyroid and genital gland. The average of ED (effective dose) was 18.43${\pm}$6.63 mSv per person and the average of radiation dose of thyroid and genital gland was 0.37 mSv, 0.77 mSv, respectively. The mean radiation dose of operators who wear the protector was 0.07 mSv for thyroid, and 0.01 mSv for genital gland, respectively. All staffs involved in TACE treatment, have to keep them aware and use the appropriate protectors to reduce the radiation dose of patient.

• Radiation Oncology Journal
• /
• v.10 no.2
• /
• pp.267-275
• /
• 1992

Remote afterloading high dose rate brachytherapy (HDRB) is a new technology and needs new biological principle for time and dose schedule. Here, authors attempt to evaluate the technique and clinical outcome in 116 patients, 590 procedures peformed at Asan Medical Center for 3 years. From Sep. 1989 to Aug 1992, 471 procedures of intracavitary radiation in 58 patients of cervical cancer and 26 of nasopharyngeal cancer,79 intraluminal radiation in 12 of esophageal cancer, 11 of endobronchial cancer and 1 Klatskin tumor and 40 interstitial brachytherapy in 4 of breast cancer, 1 sarcoma and 1 urethral cancer were performed. Median follow-up was 7 months with range $1\~31$ months. All procedures except interstitial were performed under the local anesthesia and they were all well tolerated and completed the planned therapy except 6 patients. 53/58 patients with cervical cancer and 22/26 patients with nasopharynx cancer achieved CR. Among 15 patients with palliative therapy, $80{\%}$ achieved palliation. We will describe the details of the technique and results in the text. To evaluate biologic effects of HDRB and optimal time/dose/fractionation schedule, we need longer follow-up. But authors feel that HDRB with proper fractionation schedule may yield superior results compared to the low dose rate brachytherapy considering the advantages of HDRB in safety factor for operator, better control of radiation dose and volume and patients comfort over the low dose brachytherapy.